Amphastar Pharmaceuticals (AMPH) Buildings (2013 - 2015)

Amphastar Pharmaceuticals' Buildings history runs 3 years deep, the most recent figure standing at $67.8 million for Q2 2015.

• On a quarterly basis, Buildings rose 5.71% year-over-year to $67.8 million in Q2 2015; TTM through Jun 2015 was $67.8 million, a 5.71% increase from a year earlier, with the FY2014 full-year figure at $67.8 million, up 15.05% from the prior year.
• Buildings climbed to $67.8 million in Q2 2015 per AMPH's latest filing, from $67.4 million in the prior quarter.
• Across five years, Buildings topped out at $67.8 million in Q2 2015 and bottomed at $58.9 million in Q4 2013.
• The 3-year median for Buildings is $67.1 million (2014), against an average of $65.5 million.
• Across the five-year window, Buildings gained 15.05% in 2014 and rose 5.71% in 2015, its largest moves.
• Year by year, Buildings stood at $58.9 million in 2013, then gained by 15.05% to $67.8 million in 2014, then increased by 0.09% to $67.8 million in 2015.
• Per Business Quant, the three latest AMPH Buildings figures stand at $67.8 million (Q2 2015), $67.4 million (Q1 2015), and $67.8 million (Q4 2014).